tiprankstipranks
Trending News
More News >
Scholar Rock Holding (SRRK)
:SRRK
US Market

Scholar Rock Holding (SRRK) Stock Forecast & Price Target

Compare
403 Followers
See the Price Targets and Ratings of:

SRRK Analyst Ratings

Strong Buy
8Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Scholar
Rock Holding
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SRRK Stock 12 Month Forecast

Average Price Target

$51.00
▲(48.99%Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Scholar Rock Holding in the last 3 months. The average price target is $51.00 with a high forecast of $57.00 and a low forecast of $48.00. The average price target represents a 48.99% change from the last price of $34.23.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","19":"$19","32":"$32","45":"$45","58":"$58"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$57.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":51,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$51.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$48.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,19,32,45,58],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.76,31.855384615384615,33.95076923076923,36.04615384615385,38.14153846153846,40.23692307692308,42.332307692307694,44.42769230769231,46.52307692307693,48.618461538461546,50.713846153846156,52.809230769230766,54.90461538461538,{"y":57,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.76,31.393846153846155,33.027692307692305,34.66153846153846,36.29538461538462,37.92923076923077,39.56307692307692,41.19692307692308,42.830769230769235,44.464615384615385,46.098461538461535,47.73230769230769,49.36615384615385,{"y":51,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.76,31.163076923076925,32.566153846153846,33.96923076923077,35.37230769230769,36.77538461538462,38.17846153846154,39.58153846153846,40.98461538461538,42.387692307692305,43.79076923076923,45.19384615384615,46.596923076923076,{"y":48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.96,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.39,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.06,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.45,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.42,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.96,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.22,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.38,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.82,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.06,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.76,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.76,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$57.00Average Price Target$51.00Lowest Price Target$48.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on SRRK
Evan SeigermanBMO Capital
BMO Capital
$57
Buy
66.52%
Upside
Reiterated
06/05/25
Positive Outlook on Scholar Rock's Apitegromab Driven by Promising Trial Results and Potential in Obesity and SMA Treatment
Piper Sandler Analyst forecast on SRRK
Allison BratzelPiper Sandler
Piper Sandler
$52
Buy
51.91%
Upside
Reiterated
06/04/25
Piper Sandler Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
LifeSci Capital Analyst forecast on SRRK
Dennis KennedyLifeSci Capital
LifeSci Capital
$48
Buy
40.23%
Upside
Reiterated
06/03/25
Promising Potential in Scholar Rock's Obesity and SMA Programs Drives Buy Rating
H.C. Wainwright Analyst forecast on SRRK
Andres Y. MaldonadoH.C. Wainwright
H.C. Wainwright
$50
Buy
46.07%
Upside
Reiterated
05/15/25
Analyst Recommends 'Buy' for Scholar Rock Holdings Amid Promising Developments in Apitegromab for Neuromuscular Diseases
Raymond James Analyst forecast on SRRK
Unknown AnalystRaymond James
Not Ranked
Raymond James
$49
Buy
43.15%
Upside
Reiterated
05/15/25
1Q Update: Optimistic for Timely SMA Approval... We remain Strong Buy on SRRK
TD Cowen Analyst forecast on SRRK
Marc FrahmTD Cowen
TD Cowen
Buy
Reiterated
05/14/25
Promising Pipeline and Regulatory Progress Drive Buy Rating for Scholar Rock Holding
Truist Financial Analyst forecast on SRRK
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Reiterated
05/13/25
Scholar Rock Holding (SRRK) Receives a Buy from Truist Financial
Wedbush
$50
Buy
46.07%
Upside
Initiated
03/17/25
Jefferies Analyst forecast on SRRK
Michael YeeJefferies
Jefferies
$50
Buy
46.07%
Upside
Reiterated
02/27/25
Strategic Positioning and Market Potential: Scholar Rock Holding's Buy Rating Amidst SMA and Obesity Treatment Opportunities
J.P. Morgan Analyst forecast on SRRK
Unknown AnalystJ.P. Morgan
Not Ranked
J.P. Morgan
$18$31
Buy
-9.44%
Downside
Reiterated
10/14/24
Scholar Rock (SRRK) PT Raised to $31 at JPMorganJPMorgan raised its price target on Scholar Rock (NASDAQ: SRRK) to $31.00 (from $18.00) while maintaining a Overweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on SRRK
Evan SeigermanBMO Capital
BMO Capital
$57
Buy
66.52%
Upside
Reiterated
06/05/25
Positive Outlook on Scholar Rock's Apitegromab Driven by Promising Trial Results and Potential in Obesity and SMA Treatment
Piper Sandler Analyst forecast on SRRK
Allison BratzelPiper Sandler
Piper Sandler
$52
Buy
51.91%
Upside
Reiterated
06/04/25
Piper Sandler Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
LifeSci Capital Analyst forecast on SRRK
Dennis KennedyLifeSci Capital
LifeSci Capital
$48
Buy
40.23%
Upside
Reiterated
06/03/25
Promising Potential in Scholar Rock's Obesity and SMA Programs Drives Buy Rating
H.C. Wainwright Analyst forecast on SRRK
Andres Y. MaldonadoH.C. Wainwright
H.C. Wainwright
$50
Buy
46.07%
Upside
Reiterated
05/15/25
Analyst Recommends 'Buy' for Scholar Rock Holdings Amid Promising Developments in Apitegromab for Neuromuscular Diseases
Raymond James Analyst forecast on SRRK
Unknown AnalystRaymond James
Not Ranked
Raymond James
$49
Buy
43.15%
Upside
Reiterated
05/15/25
1Q Update: Optimistic for Timely SMA Approval... We remain Strong Buy on SRRK
TD Cowen Analyst forecast on SRRK
Marc FrahmTD Cowen
TD Cowen
Buy
Reiterated
05/14/25
Promising Pipeline and Regulatory Progress Drive Buy Rating for Scholar Rock Holding
Truist Financial Analyst forecast on SRRK
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Reiterated
05/13/25
Scholar Rock Holding (SRRK) Receives a Buy from Truist Financial
Wedbush
$50
Buy
46.07%
Upside
Initiated
03/17/25
Jefferies Analyst forecast on SRRK
Michael YeeJefferies
Jefferies
$50
Buy
46.07%
Upside
Reiterated
02/27/25
Strategic Positioning and Market Potential: Scholar Rock Holding's Buy Rating Amidst SMA and Obesity Treatment Opportunities
J.P. Morgan Analyst forecast on SRRK
Unknown AnalystJ.P. Morgan
Not Ranked
J.P. Morgan
$18$31
Buy
-9.44%
Downside
Reiterated
10/14/24
Scholar Rock (SRRK) PT Raised to $31 at JPMorganJPMorgan raised its price target on Scholar Rock (NASDAQ: SRRK) to $31.00 (from $18.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Scholar Rock Holding

1 Month
xxx
Success Rate
5/10 ratings generated profit
50%
Average Return
+30.31%
initiated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +30.31% per trade.
3 Months
xxx
Success Rate
7/10 ratings generated profit
70%
Average Return
+62.81%
initiated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +62.81% per trade.
1 Year
Allison BratzelPiper Sandler
Success Rate
10/10 ratings generated profit
100%
Average Return
+118.91%
reiterated a buy rating 6 days ago
Copying Allison Bratzel's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +118.91% per trade.
2 Years
xxx
Success Rate
10/10 ratings generated profit
100%
Average Return
+189.76%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +189.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SRRK Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
1
1
3
6
9
Buy
9
12
11
8
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
13
14
14
13
In the current month, SRRK has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SRRK average Analyst price target in the past 3 months is 51.00.
Each month's total comprises the sum of three months' worth of ratings.

SRRK Financial Forecast

SRRK Earnings Forecast

Next quarter’s earnings estimate for SRRK is -$0.63 with a range of -$0.69 to -$0.57. The previous quarter’s EPS was -$0.67. SRRK beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.13% of the time in the same period. In the last calendar year SRRK has Preformed in-line its overall industry.
Next quarter’s earnings estimate for SRRK is -$0.63 with a range of -$0.69 to -$0.57. The previous quarter’s EPS was -$0.67. SRRK beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.13% of the time in the same period. In the last calendar year SRRK has Preformed in-line its overall industry.

SRRK Sales Forecast

Next quarter’s sales forecast for SRRK is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SRRK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year SRRK has Preformed in-line its overall industry.
Next quarter’s sales forecast for SRRK is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SRRK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year SRRK has Preformed in-line its overall industry.

SRRK Stock Forecast FAQ

What is SRRK’s average 12-month price target, according to analysts?
Based on analyst ratings, Scholar Rock Holding’s 12-month average price target is 51.00.
    What is SRRK’s upside potential, based on the analysts’ average price target?
    Scholar Rock Holding has 48.99% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SRRK a Buy, Sell or Hold?
          Scholar Rock Holding has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Scholar Rock Holding’s price target?
            The average price target for Scholar Rock Holding is 51.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $57.00 ,the lowest forecast is $48.00. The average price target represents 48.99% Increase from the current price of $34.23.
              What do analysts say about Scholar Rock Holding?
              Scholar Rock Holding’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of SRRK?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis